Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - PRECISION BIOSCIENCES INC | dtil-ex321_1114.htm |
| EX-31.2 - EX-31.2 - PRECISION BIOSCIENCES INC | dtil-ex312_1117.htm |
| EX-31.1 - EX-31.1 - PRECISION BIOSCIENCES INC | dtil-ex311_1116.htm |
| EX-23.1 - EX-23.1 - PRECISION BIOSCIENCES INC | dtil-ex231_788.htm |
| EX-21.1 - EX-21.1 - PRECISION BIOSCIENCES INC | dtil-ex211_789.htm |
| EX-10.14 - EX-10.14 - PRECISION BIOSCIENCES INC | dtil-ex1014_281.htm |
| EX-10.11 - EX-10.11 - PRECISION BIOSCIENCES INC | dtil-ex1011_1877.htm |
| EX-10.9 - EX-10.9 - PRECISION BIOSCIENCES INC | dtil-ex109_787.htm |
| EX-10.6 - EX-10.6 - PRECISION BIOSCIENCES INC | dtil-ex106_280.htm |
| EX-10.5 - EX-10.5 - PRECISION BIOSCIENCES INC | dtil-ex105_279.htm |
| EX-10.1 - EX-10.1 - PRECISION BIOSCIENCES INC | dtil-ex101_786.htm |
| EX-4.5 - EX-4.5 - PRECISION BIOSCIENCES INC | dtil-ex45_1557.htm |
| 10-K - 2020 10-K - PRECISION BIOSCIENCES INC | dtil-10k_20201231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Precision BioSciences, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: March 18, 2021 |
|
By: |
/s/ John Alexander Kelly |
|
|
|
|
John Alexander Kelly |
|
|
|
|
Interim Chief Financial Officer |
|
|
|
|
(principal financial officer) |